Abstract
AbstractGenome editing technologies hold great promise for numerous applications including the understanding of cellular and disease mechanisms and the development of gene and cellular therapies. Achieving high editing frequencies is critical to these research areas and to achieve the overall goal of being able to manipulate any target with any desired genetic outcome. However, gene editing technologies sometimes suffer from low editing efficiencies due to several challenges. This is often the case for emerging gene editing technologies, which require assistance for translation into broader applications. Enrichment strategies can support this goal by selecting gene edited cells from non-edited cells. In this review, we elucidate the different enrichment strategies, their many applications in non-clinical and clinical settings, and the remaining need for novel strategies to further improve genome research and gene and cellular therapy studies.
Funder
Sundhedsstyrelsen
HORIZON EUROPE European Research Council, ERC starting grant
HORIZON EUROPE Research and Innovation Actions
Lundbeckfonden
Danmarks Frie Forskningsfond
Aarhus Universitets Forskningsfond
Novo Nordisk Fonden
Innovationsfonden
Carlsbergfondet
Slagtermester Max Wørzner og Hustru Inger Wørzners Mindelegat
Den A. P. Møllerske Støttefond
Riisfort Fonden
Agnes og Poul Friis Fond
Genome Engineer Innovation Grant, Synthego
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biochemistry (medical),Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献